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A B S T R A C T
T4 lysozyme (T4L) is an importantmodel system for investigating the relationship between protein structure and
function. Despite being extensively studied, a reliable, quantitative activity assay for T4L has not been developed.
Here, we present an improved T4L turbidity assay as well as an affinity-based T4L expression and purification
protocol. This assay is designed for 96-well format and utilizes conditions amenable for both T4L and other
lysozymes. This protocol enables easy, efficient, and quantitative characterization of T4L variants and allows
comparison between different lysozymes. Our method:
 Is applicable for all lysozymes, with enhanced sensitivity for T4 lysozyme compared to other 96-well plate
turbidity assays;
 Utilizes standardized conditions for comparing T4 lysozyme variants and other lysozymes; and
 Incorporates a simplified expression and purification protocol for T4 lysozyme.
ã 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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Method
T4 lysozyme expression
Genes encoding T4 lysozyme (T4L) and an enzymatically inactive variant, T4L-E11H, were cloned
into an expression systemwhich allows easy expression in E. coli and purification. A pseudo-wild-type
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cysteine-free T4L and T4L-E11H (also cysteine-free) were amplified from Addgene constructs
18111 and 18226, respectively, and cloned into pJExpress (DNA2.0) with a C-terminal TEV protease
cleavage site and His6 tag.
1. Grow DH5a E. coli harboring the T4L-containing plasmid at 37 C to OD600 [47_TD$DIFF]1.0.
2. Induce expression with 1mM IPTG and incubate cells at 30 C for an additional hour. Note that
additional growth time following induction may result in lower yield due to lysis by T4 lysozyme.
3. Spin down cells at 3000 g for 20min at 4 C. Proceed immediately to purification or store the
pellet at 20 C overnight, or 80 C for longer periods.
Metal affinity purification
We used a standard batch/column purification with TALON resin (Clontech), with the specific
variations described below. However, any metal affinity purification should work, provided the
sodium chloride concentration is kept high to improve protein solubility.
1. Lyse cells by incubation in lysis buffer [30mM potassium phosphate pH 7.6, 0.5M NaCl, 5%
glycerol, 5mM Imidazole pH 8.0, 2mM MgCl2, 1X HALT protease inhibitor (Thermo Scientific),
0.5mg/ [48_TD$DIFF]mL1 hen eggwhite lysozyme (HEWL;MP Biomedicals)] followed by sonication for 310 s
on ice.
2. Clarify resin at 27,000 g for 20min at 4 C.
3. Incubate clarified lysatewith TALON resin (Clontech) for 15min at room temperature, according to
the manufacturer’s instructions.
4. Wash resin twice with 10 bed volumes of wash buffer (30mM potassium phosphate pH 7.6, 0.5M
NaCl, 5% glycerol, 5mM Imidazole pH 8.0), according to the manufacturer’s instructions.
5. Transfer the resin to column housing, and wash once more with 10 bed volumes of wash buffer.
6. Elute the proteinwith elution buffer (30mM potassium phosphate pH 7.6, 0.5M NaCl, 5% glycerol,
150mM Imidazole pH 8.0), collected in 1 bed volume fractions.
7. To cleave the His6 tag of T4 lysozyme, add His6-tagged tobacco etch virus (TEV) protease (1:25) to
protein-containing fractions, and pool the protein-containing fractions for dialysis into TEV
cleavage buffer (30mM potassium phosphate pH 7.6, 0.5M NaCl, 5% glycerol, 1mM 2-
mercaptoethanol, 0.5mM EDTA) overnight at 4 C with one buffer change.
8. Dialyze the protein into buffer containing 30mM potassium phosphate pH 7.6, 200mM NaCl, and
5% glycerol overnight at 4 C with one buffer change.
9. Flow the protein over a TALON resin column equilibrated with dialysis buffer and collect the flow-
through, to remove proteinswhich non-specifically bind the resin and to remove the TEV protease.
10. Store the purified protein at 4 C in 30mMpotassium phosphate pH 7.6, 200mMNaCl, 5% glycerol,
and 1mM tris (2-carboxyethyl) phosphine (TCEP).
This procedure typically yields 1–10mg of highly purified protein (Fig. 1A) per liter of cell culture,[49_TD$DIFF]
and protein is stable for at least several months. Purified proteinwas monitored by circular dichroism
spectrophotometry. The spectra of both wild-type T4 lysozyme and the E11H variant were consistent
with properly folded protein under the reaction conditions, based on comparison to a previously
reported CD spectrum for this protein [1] and the spectrum shape consistent with a primarily
a-helical protein (Fig. 1B).
Turbidity activity assay
We obtained human lysozyme (HL) (Sigma) and HEWL (MP Biomedicals) commercially as solids,
although any source of lysozymes should be suitable for this assay. In general, we solubilized lysozyme
at 1.0mg/[50_TD$DIFF]mL1 in 30mM potassium phosphate pH 7.6, 200mM NaCl, 5% glycerol, 1mM TCEP, to be
consistent with the buffer of the purified T4 lysozyme.
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1. Prepare a solution of 0.3mg/[51_TD$DIFF]mL1 driedMicrococcus luteus (M. lysodeikticus; Sigma) in assay buffer
(either 30mM potassium phosphate pH 7.2 or 66mM potassium phosphate pH 6.2) and vortex
extensively (approximately 30–60 s) to suspend.
2. Allow the solution to settle for approximately 30min before performing the assay.
3. Add lysozyme diluted to a final volume of 20m [52_TD$DIFF]L in assay buffer towells of a flat-bottomed 96-well
plate, in triplicate. We typically used 1.2mg T4L and T4L-E11H, and 0.2mg HL and HEWL.
4. Immediately before monitoring OD, add 200m [52_TD$DIFF]L of the cell suspension to each well of the 96-well
plate containing lysozyme.
5. Allow reactions to proceed at 25 C immediately after adding cell suspension (no additional
mixing or shaking) and record theOD450 at 15 s intervals for 5min.We utilized a Bio-TekH1mplate
reader.
6. Following data collection, calculate the average OD of triplicate wells at each timepoint for the set
of technical replicates.
7. Obtain the slope using the average OD at each timepoint vs. time (minutes) for the consistently
linear portion of the experiment. Under our assay conditions, the linear portionwas generally the
period 0–4min for T4L and T4L-E11H, and 0–2min for HEWL and HL.
8. Convert slopes to units, where 1 unit is equivalent to a decrease in absorbance of 0.001/min1[53_TD$DIFF]
[2–5].
9. Subtract the units for a given lysozyme from the units for the corresponding buffer control and
adjust according to the amount of enzyme present in the reaction, resulting in a measure of
activity in Units [54_TD$DIFF]mg1.
10. To improve the reliability of the activity values, perform the experiment two additional times
using independent substrate preparations. Calculate final activity values and standard deviations
for the average of each experiment for each experimental condition.
Methods validation
Using the assay described above, we compared the activity of T4L, T4L-E11H (previously reported
as catalytically inactive; [6,7]), HL, andHEWL using two different assay buffer conditions (Table 1). The
first condition (30mM potassium phosphate pH 7.2) was based on previous reports that T4L prefers a
[(Fig._1)TD$FIG]
Fig. 1. Confirmation of T4 lysozyme purity and native structure. (A) Approximately 5mg of each T4 lysozyme variant assayed
were subjected to analysis by SDS-PAGE, followed by protein staining with Gelcode Blue (Thermo Scientific). Lane 1–NEB
protein ladder (10–250kDa); lane 2—T4L; lane 3—T4L-E11H; lane 4—HEWL; lane 5—HL. Under these conditions, any
contaminating proteins present at levels of 10ng or greater (0.2%) would appear, and so our preparations of T4L and T4L-E11H
are at least 99% pure. The commercially obtained HL appears slightly less pure. (B) Proteins purified during this study were
monitored by CD spectrophotometry. The spectra of 1.0mMwild-type (black circles) and E11H variant (open squares) in 30mM
potassium phosphate pH 7.2 are similar to each other and consistent with the expected structure. Spectra are an average of
4 accumulations obtained at a scan rate of 20nm/min1 [42_TD$DIFF] with a 2 s integration every 0.5 nm in a 2mm quartz cuvette.
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buffer with low ionic strength and a neutral pH [8]. The second condition (66mM potassium
phosphate pH 6.2) was previously reported for assessing activity of other lysozymes in similar assays
[4,9]. HL and HEWL were equivalently active in both buffer conditions; however, T4L only showed
measurable activity in 30mMpotassium phosphate pH 7.2 (Table 1). These findings, as well as those of
a sampling of additional ionic strength and pH conditions (data not shown), are in agreement with
previous data suggesting that the optimal conditions of T4L are different andmore restrictive than for
HEWL [8]. An assay buffer of 30mM potassium phosphate pH 7.2 allows for characterization of T4L
activity as well as other lysozymes under common conditions, in contrast to the previously reported
66mM potassium phosphate pH 6.2.
Although this protocol has a relatively low signal-to-noise ratio, the resulting slopes for the
technical replicates within a single trial are consistent over an initial period of a few minutes, even
when the absolute absorbance values vary substantially (Fig. 2). The reasonable agreement between
triplicate experiments, represented by the standard deviations calculated from three independent
trials (where each trial had 3 technical replicates), indicates that the activity measurement is quite
reproducible (Table 1) despite using approximately 10-fold less lysozyme (all types) per reaction than
has been reported in other methods [2,9–12], and with sensitivity similar to that of muchmore labor-
intensive E. coli-based assays [13]. Thus, even though the signal-to-noise ratio is relatively low for a
single replicate with this assay, performing technical triplicates within each of three independent
experiments allows for the reliable quantification of lysozyme activity with significantly lower
enzyme concentrations, and the signal intensity can be enhanced by using greater amounts of enzyme
at the expense of a shorter linear reaction time.
Several parameters of the assay are critical for obtaining reproducible activity measurements for
T4L. First, the 30minute time allowance between cell suspension and the start of the assay was
optimal for cells to rehydrate and settle appropriately. Allowing significantly less time for cell
hydration resulted in more experimental noise. Conversely, allowing cells to settle for additional time
resulted in a time-dependent decrease in the OD450 at the start of the experiment, also leading to a
lower signal-to-noise ratio (data not shown). Furthermore, additional mixing performed by the plate
reader, as reported in a similar lysozyme assay [2], resulted in increased noise without significantly
affecting the activity measurements when performed during this protocol (data not shown). Finally, a
highly purified enzyme is critical for generating reproducible activity values. Although the yield of T4L
by our method is lower than the reported 16–23mg [55_TD$DIFF]L1 yield for a previously developed and
commonly used protocol [14], the exceptional purity of enzyme purified here, which itself likely
contributes to the lower apparent protein yield, is more advantageous for this assay as well as other
downstream applications. In addition, the purity obtained by sequential affinity chromatography is
typically higher than that expected from another rapid purificationmethod involving cation exchange
[15].
When performing the protocol as described above, either round-bottom or flat-bottom 96-well
plates can be used. In a less-effective variation of this protocol, cells were added to wells first and
allowed to settle for 30min in the assay plate. Lysozymewas then added to the well at the start of the
assay. Thismethod results in less noise for eachwell, butmore variability between replicates (Table 2).
In addition, this approach onlyworkedwith flat-bottomplates, as allowing the cells to settle in round-
bottom plates resulted in extreme experimental noise.
Table 1
Activity and standard deviation for each lysozyme variant under our fully optimized conditions (30mM
potassium phosphate pH 7.2) and using the optimized method with previously published buffer conditions
(66mM potassium phosphate pH 6.2).
Activity U [44_TD$DIFF]mg1
Lysozyme 30mM phosphate pH 7.2 66mM phosphate pH 6.2
T4L 1.1  0.2 0.2  0.3
T4L-E11H 1.9  0.6 0.6  1.3
HEWL 25  2 29  2
HL 51  5 38  9
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Table 2
Comparison of variability for turbidity assay protocols based on three independent experiments using each method.
% Standard deviation
Lysozyme Method Aa Method Bb
T4L 20 81
T4L-E11H 30 115
HEWL 8.6 64
HL 9.3 24
a Cells were allowed to settle in a centrifuge tube before addition to the 96-well plate containing enzyme (Figure 1; Table 1).
b Cells were allowed to settle in the 96-well plate, and enzyme was added to cells.
[(Fig._2)TD$FIG]
Fig. 2. Activity of T4 lysozyme in low ionic strength buffer.M. luteus (0.3mg/ [43_TD$DIFF]mL1) in 30mM potassium phosphate pH 7.2 was
added to a 96-well plate in triplicate containing T4L (right) or buffer (left). OD450 was measured at 15 s intervals. Data shown
represents technical triplicates for three independent experiments (each replicate series as white, grey, or black). Lines
represent the best fit to each data set, to illustrate overall slope of the data within each replicate.
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Additional information
T4L is an enzyme found in T4 phage that is tolerant of mutations and amenable to crystallization.
Extensive mutagenesis and structural studies of this protein have been instrumental in our general
understandingof the relationshipbetweenproteinstructureand function [16,17].While this enzymehas
many advantages as a model system, a simple and robust activity assay has been lacking. The native
function of lysozymes is to hydrolyze bacterial cells walls, andmost assays exploit this activity. Several
turbidityassayshavebeenreported,whichmonitorthedecreaseinopticaldensityofT4L-treatedbacteria
in suspension over time [8,10,12,13,18,19]. Overall, these assays are cumbersome, sometimes involving
extensive preparation of the cell wall substrates and utilizing cuvettes which canmonitor only a single
reactionatatime[10,12,13,18,19]. Ithasalsobeenreportedthattheseassaysareonlycapableofgenerating
internally normalized rates and not absolute activity [14]. Alternative assays have been developed for
monitoring T4L activity; however, these assays also have significant drawbacks. For example, the halo
assayrequiresalongincubationperiodandisnotquantitative[20].Othersrequirespecializedequipment,
such as a CD spectrophotometer or HPLC while remaining low-throughput [1,6,21].
Multiple groups have reported activity assays for related lysozyme proteins, including HEWL and
HL. These assays monitor the decrease in turbidity of suspended bacterial cells; however, the
conditions and protocols reported for each of the assays are highly variable [2,4,9,11,22–24]. They are
more robust than the assays reported for T4L, and some have even been adapted to 96-well format, but
the assays often still suffer from substantial noise.Moreover, the assays do notworkwell for T4L, likely
due in part to the relatively low activity level of T4L compared to the others and the high sensitivity of
T4L to buffer conditions [8].
T4L-E11Hwas included in this studyas a negative control, as the E11 residuewas previously reported
to be required for enzymatic activity [6,7]. Based on these reports,we expected the E11Hvariant (aswell
as a buffer control) to result in no change inOD450 over time in our assay. Instead, the OD450 consistently
increasedduring thecourseof theexperimentwhencellswere incubatedwithT4L-E11H(Table1).While
we also observed this phenomenon with the buffer control, it was much more pronounced in the
presence of T4L-E11H. This observation suggests that some of the T4L activity may be masked by the
tendency of T4L to increase the OD450 in the absence of enzymatic activity, and that subtraction of T4L-
E11Hactivity, rather thanbuffer,maybemoreappropriate fordeterminingT4Lactivity.Nevertheless,we
observed a decrease in turbidity only when active enzymewas present in the reaction, consistent with
prior reports that decreased turbidity in this assay correlates with enzyme activity [8,10,12,13,18,19].
Although the reason for the increase in OD450 is not known, it indicates that the activitymeasurements
presentedforT4L,bothhereandinother reports,maybelowerthantheactualactivityof theenzyme.The
mechanism behind the increase in light scattering revealed by our assay could be the subject of future
studies using other catalytically inactive lysozymes.
Here, we have presented a simple, robust activity assay in 96-well format that can quantitatively
measure the activity of T4L, and is also appropriate for evaluating other lysozyme variants. This assay
is facile, rapid, cost-effective, and provides quantitative activitymeasurements for T4L aswell as other
lysozyme proteins using a single set of reaction conditions. By performing the assay in 96-well format,
multiple lysozyme variants can be simultaneously assayed for activity, which will facilitate the
characterization of lysozyme variants, such as in comparative studies of T4L examining the effects of
mutations on activity and for comparisons between T4L and other lysozymes, and lead to a more
comprehensive understanding of the relationship between protein structure and function.
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